Abstract: Described are methods for providing a pulsed dose of a gaseous drug over a portion of total inspiratory time, where the dose of the gaseous drug is delivered at a concentration of nL of gaseous drug per mL tidal volume.

Abstract: Described are methods for maintaining or improving activity levels in patients lung-related conditions.

Abstract: Described are methods for providing a pulsed dose of nitric oxide during at least the first two-thirds of total inspiratory time in each single breath for a therapeutically relevant period of time.

Abstract: Described herein are methods of treating pulmonary hypertension by maintaining dosing frequency and/or minimizing skipped breaths during pulsed administration of inhaled nitric oxide.

Abstract: The present specification provides a novel process platform that replaces paper-based work instructions and data collection used for manufacturing products. Specifically, the present specification provides a method and platform for performing automated testing of a product being manufactured. The process platform of the present invention may be deployed at multiple locations and be integrated with existing quality control systems. The process platform includes a plurality of pre-defined instructions and is programmed to execute these instructions automatically at different stages for performing desired quality checks on the product being manufactured at multiple manufacturing stages.